The Time to Evaluate the Impact of PET PSMAs on Management of Prostate Cancer Is Now
Int J Radiat Oncol Biol Phys
.
2022 Jun 1;113(2):254-255.
doi: 10.1016/j.ijrobp.2021.04.037.
Authors
Osama Mohamad
1
,
Felix Feng
2
Affiliations
1
Department of Radiation Oncology, University of California, San Francisco, California. Electronic address: Osama.Mohamad@ucsf.edu.
2
Department of Radiation Oncology, University of California, San Francisco, California.
PMID:
35569471
DOI:
10.1016/j.ijrobp.2021.04.037
No abstract available
Publication types
Letter
Comment
MeSH terms
Gallium Radioisotopes
Humans
Male
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / radiotherapy
Substances
Gallium Radioisotopes